Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

ABB Ltd

Rockwell Automation

My task today is to identify three robotics stocks to buy in June that you can turn into $1 million from a $1,000 investment.  As I write this mid-way through June, the S&P 500 is already up nearly 15% on the year, while the largest U.S.-listed robotics exchange-traded fund, the Global X Robotics & Artificial Intelligence (NASDAQ: BOTZ ) with $2.75 billion in net assets, is up 43 basis points year-to-date relative to the index.

3 Robotics Stocks to Turn $1000 into $1 Million: June 2024

In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $422.90, indicating a -1.21% shift from the previous trading day.

Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: Here's Why

Intuitive Surgical can make for a good investment whether you're bullish on healthcare or artificial intelligence. The company recently launched its latest surgical system, which can benefit from advancements in AI.

Forget Nvidia, Buy This Magnificent Growth Stock Instead

Intuitive Surgical, Inc. is well-poised for growth in the coming quarters, courtesy of its strength in robotics. The optimism, led by solid results in the last few quarters and its progress on the Artificial Intelligence front, is expected to contribute further. However, procedure adoption risks and stiff competition persist.

Reasons to Retain Intuitive Surgical in Your Portfolio

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?

Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Intuitive Surgical Inc (ISRG) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Report Scope:

Intuitive Surgical (ISRG) Company Profile - 2024 Product Pipeline Analysis and Ongoing Clinical Trials Insights

Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.

Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio

Alphabet

Microsoft

Growth stocks are those that grow faster than average as measured at the top line or by revenue. If we measure growth across the S&P 500, it stands somewhere around 4% on average.

The Tortoise and the Hare: 3 Growth Stocks for Slow and Steady Wins

Intuitive Surgical (ISRG) announces the FDA clearance of revised da Vinci Xi and X Labeling on Radical Prostatectomy.

Intuitive Surgical (ISRG) Gets FDA Nod for da Vinci's New Label

Cognex

UiPath

In this article, we will explore the three most undervalued robotics stocks that savvy investors should consider adding to their portfolios in June 2024. These companies have demonstrated strong fundamentals and fascinating technologies that are pushing the needle forward.

The 3 Most Undervalued Robotics Stocks to Buy in June 2024

Intuitive Surgical, Inc. (ISRG) reachead $418.15 at the closing of the latest trading day, reflecting a +0.22% change compared to its last close.

Intuitive Surgical, Inc. (ISRG) Increases Despite Market Slip: Here's What You Need to Know

AeroVironment

Samsara

iRobot

Symbotic Inc

Zebra Technologies

Contrary to the dramatic headlines about robots replacing human workers, a robotics & automation revolution is quietly reshaping multiple industries — changing their entire faces rather than just swapping one form of labor for another. But there's a hitch for retail investors: many of the most innovative robotics & automation stocks remain private, limiting public investment opportunities.

7 Robotics & Automation Stocks to Own Before They Transform Industries

FDA review of historic data shows patients who received robotic prostatectomies have overall cancer survival rates on par with open surgery FDA review of historic data shows patients who received robotic prostatectomies have overall cancer survival rates on par with open surgery

Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy

American Century Focused Dynamic Growth ETF

HubSpot

Regeneron Pharmaceuticals

What better way to get a sense of an ETF than to understand its stocks? One key challenge for investors right now — avoiding overconcentration risk from the big, big tech names — merits looking for strategies outside that space.

3 Stocks to Watch in Active Growth ETF FDG

Global X Robotics & Artificial Intelligence ETF

Teradyne

AI technology is expected to turbocharge growth in robotics as it moves beyond programmed tasks to an adaptive learning system. However, both technologies are still in their nascency, offering tremendous long-term upside potential in robotics stocks to buy.

If You Can Only Buy One Robotics Stock This Summer, It Better Be One of These 3 Names

DexCom

Intuitive Surgical will benefit as the need grows for procedures using its robotic devices. DexCom provides critical devices to the increasing population of diabetes patients.

Bull Market Buys: 2 Growth Stocks to Own for the Long Haul

Tesla

Have you ever heard of the uncanny valley? It refers to the unsettling feeling humans sometimes experience when seeing a humanoid robot or generated face, for example.

Uncanny Profits: 3 AI Robot Stocks to Own Despite the Creep Factor

Eli Lilly

Novo Nordisk

Universal Health Services

Vertex Pharmaceuticals

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

S&P 500 Giants Lead Five Healthy Stocks Near Buy Points

Markel

SharkNinja Inc

Valley National

Acuity Brands

Deere & Company

Finding the best retirement stocks that perfectly align with every investor's portfolio is challenging. Numerous factors influence the decision tree, including your retirement account's tax structure, age, risk tolerance and personal investment preferences.

Retirement Stocks to Buy: 7 Picks Offering Value, Growth and Dividends

As Intuitive Surgical gets FDA clearance for its next-gen robotic surgery system, ISRG stock teases a new breakout.

With FDA Clearance, Intuitive Surgical Operates On New Breakout

Johnson & Johnson

Stryker

While the biotechnology sector may receive most of the attention under the broad healthcare umbrella, investors ought to spare some love for medical technology stocks. The enterprises undergirding these securities offer tremendously positive potential for overall patient outcomes.

HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom

Intuitive Surgical (ISRG) shares gain on the back of growth in the da Vinci treatment volume and raised procedure prices.

Intuitive Surgical (ISRG) Stock Gains 20% YTD: Here's Why

Amazon

Vici Properties

A handful of top S&P 500 stocks to buy tend to take the spotlight, many with good reason. Still, companies like Nvidia (NASDAQ: NVDA ) comprise an increasingly high position in the index's overall ranking and that is reasonable cause for concern for those prioritizing effective diversification planning.

If You Can Only Buy One S&P 500 Stock in May, It Better Be One of These 7 Names

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $404.85, signifying a +1.62% move from its prior day's close.

Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider

HCA Healthcare

UnitedHealth Group

With healthcare spending projected to grow 5.4% annually through 2031, healthcare stocks remain highly compelling investments in the current market. As one of the few sectors with near-guaranteed growth trajectories thanks to constant consumer demand, healthcare stocks to buy right now present investors with stability and upside.

News for Intuitive Surgical Stock (ISRG)